This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Oscar Health, Inc. (OSCR) Falls More Steeply Than Broader Market: What Investors Need to Know
by Zacks Equity Research
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $22.93, representing a -1.46% change from its previous close.
AXAHY vs. OSCR: Which Stock Is the Better Value Option?
by Zacks Equity Research
AXAHY vs. OSCR: Which Stock Is the Better Value Option?
Oscar Health, Inc. (OSCR) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $21, representing a +1.6% change from its previous close.
Strength Seen in Oscar Health (OSCR): Can Its 18.7% Jump Turn into More Strength?
by Zacks Equity Research
Oscar Health (OSCR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Brokers Suggest Investing in Oscar Health (OSCR): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Oscar Health (OSCR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
AIZ or OSCR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AIZ vs. OSCR: Which Stock Is the Better Value Option?
Should You Invest in the SPDR S&P Insurance ETF (KIE)?
by Zacks Equity Research
Sector ETF report for KIE
AIZ vs. OSCR: Which Stock Is the Better Value Option?
by Zacks Equity Research
AIZ vs. OSCR: Which Stock Is the Better Value Option?
Oscar Health, Inc. (OSCR) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Oscar Health (OSCR) delivered earnings and revenue surprises of 25% and 1.72%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Here's What to Expect From HCI Group (HCI) in Q2 Earnings
by Zacks Equity Research
HCI Group's (HCI) second-quarter results are likely to benefit from better performances across its business units.
Is a Beat in Store for Oscar Health (OSCR) in Q2 Earnings?
by Zacks Equity Research
Oscar Health's (OSCR) Q2 results are likely to reflect membership growth, prudent pricing and improved cost-of-care initiatives.
Here's What to Expect From Assurant (AIZ) in Q2 Earnings
by Zacks Equity Research
Assurant's (AIZ) Q2 results are likely to reflect higher yields and assets in fixed maturity securities, lower catastrophe reinsurance premiums, higher premium rates and growth in Connected Living.
ETFs & Stocks in Focus on Kamala Harris' Shift in Strategy
by Sanghamitra Saha
Analysts have noticed that Harris's 2024 campaign for president is a bit different than what it was in 2024, as quoted on yahoo finance.
Prudential (PRU) Misses Q2 Earnings Estimates
by Zacks Equity Research
Prudential (PRU) delivered earnings and revenue surprises of -1.17% and 0.41%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Enact Holdings, Inc. (ACT) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Enact Holdings (ACT) delivered earnings and revenue surprises of 23.30% and 2.29%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Oscar Health, Inc. (OSCR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $17.68, representing a +1.67% change from its previous close.
Oscar Health, Inc. (OSCR) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Oscar Health (OSCR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Allstate (ALL) Q2 Earnings Beat Estimates on Premium Growth?
by Zacks Equity Research
Allstate's (ALL) second-quarter results are likely to reflect growing net investment income.
Will American International's (AIG) Q2 Earnings Hit a Pothole?
by Zacks Equity Research
American International's (AIG) second-quarter results are likely to reflect lower profits from General Insurance.
Will Prudential (PRU) Pull Off a Surprise in Q2 Earnings?
by Zacks Equity Research
Prudential's (PRU) Q2 results are likely to reflect higher spread income, equity market appreciation and growth in indexed variable annuities, partially offset by lower underwriting results.
Is Oscar Health (OSCR) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Oscar Health, Inc. (OSCR) and Acadia Realty Trust (AKR) have performed compared to their sector so far this year.
Will Rising Expenses Play Spoilsport for AON's Q2 Earnings?
by Zacks Equity Research
AON's second-quarter results are likely to reflect growing contributions from its Health Solutions unit.
Do Options Traders Know Something About Oscar Health (OSCR) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Oscar Health (OSCR) stock based on the movements in the options market lately.
Is SPDR S&P Insurance ETF (KIE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KIE
Oscar Health, Inc. (OSCR) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $16.19, representing a +1.19% change from its previous close.